Infectious Bronchitis in Poultry
Infectious Bronchitis in Poultry
Practical Overview & Field Action
At a Glance
- Severity Level: High
What You May Notice
- Early Signs: Tracheal rales, coughing, sneezing, nasal discharge, wet eyes, severe depression. Nephrotropic: severe dehydration, increased water consumption (polydipsia)
- Advanced Symptoms: Drop in egg production (up to 50%); thin-shelled, misshapen, or shell-less eggs with watery, thin albumen. Targets respiratory, renal, and urogenital systems.
- Postmortem Findings: Catarrhal tracheitis, lung congestion, serous/caseous exudate in air sacs. Nephrotropic: swollen pale kidneys with urate deposits. Layers: cystic right oviduct.
Field Verification Checkpoints
- Field Verification: Respiratory signs paired with specific eggshell/albumen defects and polydipsia.
- Laboratory Confirmation: RT-PCR targeting S1 gene, sequencing for serotype, virus isolation in embryonated eggs (embryo dwarfing/curling), ELISA
- Differential Possibilities: Newcastle Disease, Infectious Laryngotracheitis, Mycoplasmosis
Prevention & Control Action
- Vaccination Control: Hatchery standard or field boosting
- Biosecurity Action: Standard biosecurity protocols
Identity
An acute, highly contagious viral disease caused by a single-stranded RNA Gammacoronavirus. It targets the respiratory, renal, and reproductive systems, causing severe respiratory disease, renal pathology (urolithiasis), watery egg whites, and a permanent drop in egg production.
Overview
Infectious Bronchitis (IBV) is a high-priority viral pathogen globally distributed and paramount to broiler and layer industries. The virus replicates in ciliated epithelial cells of the trachea causing deciliation, while variant strains are highly nephrotropic or target the oviduct. It causes watery egg whites and significant drops in egg production (up to 50%). Prevention relies on managing optimal air exchange to reduce environmental ammonia (which exacerbates ciliary damage) and administering specific live attenuated or inactivated vaccines (e.g., Mass-type H120, ND+IB+EDS Killed). IBV mucosal damage strongly predisposes flocks to secondary colisepticemia (APEC).
Structured Facts
Classification
Viral > Infectious Pathogen
Epidemiology
- Severity: High
- Affected Species: Poultry (Layers and young chicks highly impacted)
- Affected Age: All age classes; chicks < 3 weeks at highest risk of mortality and permanent damage
- Transmission: Extremely rapid horizontal spread via airborne aerosols, direct contact, and mechanical transmission
- Mortality: < 5% (uncomplicated), up to 30% (nephrotropic strains in young chicks)
- Morbidity: Approaches 100% in naive populations
- Economic Importance: High
Clinical Signs
- Early/Intermediate: Tracheal rales, coughing, sneezing, nasal discharge, wet eyes, severe depression. Nephrotropic: severe dehydration, increased water consumption (polydipsia)
- Advanced: Drop in egg production (up to 50%); thin-shelled, misshapen, or shell-less eggs with watery, thin albumen. Targets respiratory, renal, and urogenital systems.
- Postmortem Findings: Catarrhal tracheitis, lung congestion, serous/caseous exudate in air sacs. Nephrotropic: swollen pale kidneys with urate deposits. Layers: cystic right oviduct.
Diagnosis
- Field Diagnosis: Respiratory signs paired with specific eggshell/albumen defects and polydipsia.
- Laboratory Tests: RT-PCR targeting S1 gene, sequencing for serotype, virus isolation in embryonated eggs (embryo dwarfing/curling), ELISA
- Differential Diagnosis: Newcastle Disease, Infectious Laryngotracheitis, Mycoplasmosis
Treatment
- Medicines: None exist
Prevention
- Vaccination: IB H120 (Spray / Intraocular drop) at day-old; ND+IB+EDS Killed (Subcutaneous / Intramuscular injection)
- Biosecurity: Standard biosecurity protocols
- Farm Management: Maintain optimal air exchange to reduce environmental ammonia levels
Quantitative Data
- Morbidity Rate: ~100%
- Mortality Rate: < 5% (uncomplicated); up to 30% (nephrotropic)
- Egg Production Drop: Up to 50%
Relationships
- Vaccines: IB H120, ND+IB+EDS Killed
- Medicines: None
- Synergistic/Predisposing Factors: Ammonia Toxicity (exacerbates ciliary damage), Escherichia coli (Colibacillosis)